文献速递骨肿瘤关节外科

肿瘤适应证行股骨近端假体置换术后髋关节稳定性:患者与手术技术相关变量分析

The stability of the hip after the use of a proximal femoral endoprosthesis for oncological indications: analysis of variables relating to the patient and the surgical technique.
PubMed 文献 · Bone Joint J · 2017-01-01

回顾性队列研究纳入527例因肿瘤行股骨近端假体置换的成人患者,术后20例(4%)出现髋关节不稳,平均术后35天(3至131天)发生。关节囊修复与不稳发生率降低无关;后外侧入路在双变量和多变量分析中均与较低的不稳风险相关,年龄>60岁、女性、原发性恶性骨肿瘤及良性疾病在多变量分析中预测不稳。

要点

  • 527例中20例(4%)术后出现髋关节不稳,平均术后35天(3至131天)发生。
  • 关节囊修复与不稳发生率降低无关。
  • 多变量分析中年龄>60岁、女性、原发性恶性骨肿瘤及良性疾病预测不稳,后外侧入路具保护作用。

核心结论

  • 股骨近端假体置换术后髋关节稳定性受患者、病理、手术技术和假体相关变量影响。
  • 未发现关节囊修复与稳定性改善之间存在关联。
  • 作者认为采用后外侧入路、半髋关节置换及合成补片修复软组织的股骨近端假体置换 confers 最低的不稳风险(原文为 confers,照录语气)。
  • 作者认为高龄、女性、原发性良性或恶性骨肿瘤患者应被告知不稳风险增加。

研究设计与样本

  • 回顾性队列研究,纳入527例因肿瘤接受股骨近端假体置换的成人患者。
  • 数据包括人口学资料、病理诊断、外展肌切除量、重建技术和假体特征,采用回归分析比较术后不稳与无不稳患者。

主要发现

  • 527例中20例(4%)出现术后不稳,平均发生于术后35天(3至131天)。
  • 双变量分析:后外侧手术入路与不稳降低相关(OR 0.11,95%CI 0.02至0.86),假体类型与不稳降低显著相关(p=0.046),年龄>60岁预测不稳(OR 3.17,95%CI 1.00至9.98)。
  • 多变量分析:年龄>60岁(OR 5.09,95%CI 1.23至21.07)、女性(OR 1.73,95%CI 1.04至2.89)、原发性恶性骨肿瘤(OR 2.04,95%CI 1.06至3.95)、良性疾病(OR 5.56,95%CI 1.35至22.90)预测不稳,转移性疾病或软组织肿瘤未预测不稳,后外侧入路对不稳具保护作用(OR 0.09,95%CI 0.01至0.53)。
  • 70例使用合成补片的患者中未发生不稳。

临床怎么用

  • 作者认为高龄、女性、原发性良性或恶性骨肿瘤患者应被告知不稳风险增加。
  • 作者认为采用后外侧入路、半髋关节置换及合成补片修复软组织的股骨近端假体置换 confers 最低的不稳风险(原文为 confers,照录语气)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Instability of the hip is the most common mode of failure after reconstruction with a proximal femoral arthroplasty (PFA) using an endoprosthesis after excision of a tumour. Small studies report improved stability with capsular repair of the hip and other techniques, but these have not been investigated in a large series of patients. The aim of this study was to evaluate variables associated with the patient and the operation that affect post-operative stability. We hypothesised an association between capsular repair and stability. PATIENTS AND METHODS: In a retrospective cohort study, we identified 527 adult patients who were treated with a PFA for tumours. Our data included demographics, the pathological diagnosis, the amount of resection of the abductor muscles, the techniques of reconstruction and the characteristics of the implant. We used regression analysis to compare patients with and without post-operative instability. RESULTS: A total of 20 patients out of 527 (4%) had instability which presented at a mean of 35 days (3 to 131) post-operatively. Capsular repair was not associated with a reduced rate of instability. Bivariate analysis showed that a posterolateral surgical approach (odds ratio (OR) 0.11, 95% confidence interval (CI) 0.02 to 0.86) and the type of implant (p = 0.046) had a significant association with reduced instability; age > 60 years predicted instability (OR 3.17, 95% CI 1.00 to 9.98). Multivariate analysis showed age > 60 years (OR 5.09, 95% CI 1.23 to 21.07), female gender (OR 1.73, 95% CI 1.04 to 2.89), a malignant primary bone tumour (OR 2.04, 95% CI 1.06 to 3.95), and benign condition (OR 5.56, 95% CI 1.35 to 22.90), but not metastatic disease or soft-tissue tumours, predicted instability, while a posterolateral approach (OR 0.09, 95% CI 0.01 to 0.53) was protective against instability. No instability occurred when a synthetic graft was used in 70 patients. CONCLUSION: Stability of the hip after PFA is influenced by variables associated with the patient, the pathology, the surgical technique and the implant. We did not find an association between capsular repair and improved stability. Extension of the tumour often dictates surgical technique; however, our results indicate that PFA using a posterolateral approach with a hemiarthroplasty and synthetic augment for soft-tissue repair confers the lowest risk of instability. Patients who are elderly, female, or with a primary benign or malignant bone tumour should be counselled about an increased risk of instability. Cite this article: Bone Joint J 2017;99-B:531-7.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Henderson ER, Keeney BJ, Pala E, et al. The stability of the hip after the use of a proximal femoral endoprosthesis for oncological indications: analysis of variables relating to the patient and the surgical technique. Bone Joint J. 2017. PMID: 28385944. doi:10.1302/0301-620X.99B4.BJJ-2016-0960.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。